Cargando…
A Systematic Approach to Preclinical Trials in Metastatic Breast Cancer
The process of developing new agents for therapy against breast cancer is inefficient and relies on animal models to screen for efficacy for preclinical studies. However, there has been limited validation of these models, despite the increasing costs in the rapidly growing era of personalized medici...
Autores principales: | Rashid, OM, Maurente, D, Takabe, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045240/ https://www.ncbi.nlm.nih.gov/pubmed/27695662 http://dx.doi.org/10.4172/2167-7700.1000204 |
Ejemplares similares
-
Improving Gastrointestinal Cancer Care by Enhanced Recovery Protocol Implementation
por: Frankel, Lexi, et al.
Publicado: (2023) -
Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
por: Oshi, Masanori, et al.
Publicado: (2020) -
MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
por: Schulze, Amy, et al.
Publicado: (2020) -
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019) -
Live animals for preclinical medical student surgical training
por: DeMasi, Stephanie C., et al.
Publicado: (2016)